As our results suggest the utility of PAXX as a potential therapeutic target in colon cancer, we performed gene set enrichment analysis to further determine the association of PAXX expression with underlying oncogenic pathways in colon cancer. This evidence concerns the gene PAXX and malignant colon neoplasm.